Compare Aurora Cannabis Inc (ACB) vs CleanSpark Inc (CLSK) Price & Performance

Aurora Cannabis (ACB) trades at $2.71, down 4.58% on the day, with a bearish technical outlook. The company reported a net income of $1.59 million in 2025, a significant improvement from a $69 million loss in 2024, though 2026 guidance projects a net loss of $136 million. Revenue grew to $343.29 million in 2025, but faces headwinds from Canadian reimbursement pressures. Analyst consensus is mixed, with 21.43% buy, 57.14% hold, and 21.43% sell ratings.

The stock's low P/B of 0.47 suggests undervaluation, but negative profitability metrics and a projected reset year in 2027 pose risks. Investment appeal hinges on execution in high-margin international medical markets, though volatility and competitive pressures remain key concerns for shareholders.

CleanSpark (CLSK) trades at $13.51, up 7.05% today but facing bearish technical signals with recent earnings misses. The company reported strong revenue growth to $766M in 2025 but swung to a net loss margin of -67.66% in 2026. Analyst sentiment remains strongly bullish with 11 buy ratings and a $20.50 consensus target, though cash flow challenges persist with negative operating cash flow of $461M in 2025.

The stock presents a divergence between strong analyst support and challenging fundamentals. While Wall Street sees 100% upside potential, investors face execution risks from profitability challenges and volatile bitcoin mining economics. The technical setup suggests near-term pressure with the stock trading near support levels amid broader market uncertainty.